Latest News

BidaskClub upgraded shares of Digi International (NASDAQ:DGII) from a hold rating to a buy rating in a research note released on Thursday, BidAskClub reports. A number of other equities research analysts have also commented on the company. Zacks Investment Research lowered Digi International from a buy rating to a hold rating in a research report […]

IPL Plastics (TSE:IPLP) had its price target trimmed by Laurentian from C$17.25 to C$17.00 in a research note released on Thursday, BayStreet.CA reports. TSE:IPLP opened at C$9.35 on Thursday. IPL Plastics has a one year low of C$7.97 and a one year high of C$13.41. The company has a debt-to-equity ratio of 109.25, a quick […]

Maxim Group restated their buy rating on shares of Aridis Pharmaceuticals (NASDAQ:ARDS) in a research report released on Thursday morning, AnalystRatings.com reports. They currently have a $25.00 target price on the stock. “Aridis reported 2Q19 with a net loss of ($8.4M) and ended the period with $8.5M in cash on the balance sheet. This excludes […]

Deutsche Bank reissued their buy rating on shares of GVC (LON:GVC) in a research note released on Thursday morning, Digital Look reports. Deutsche Bank currently has a GBX 910 ($11.89) target price on the stock. Several other analysts have also recently weighed in on GVC. Barclays raised their price target on GVC from GBX 887 […]

Vertex Pharmaceuticals (NASDAQ:VRTX) and Novus Therapeutics (NASDAQ:NVUS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations. Insider & Institutional Ownership 94.7% of Vertex Pharmaceuticals shares are owned by institutional investors. Comparatively, 26.9% […]

ValuEngine upgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX) from a hold rating to a buy rating in a research note released on Thursday, ValuEngine reports. Several other equities research analysts have also weighed in on the company. Citigroup reissued a buy rating and set a $205.00 price objective on shares of Vertex Pharmaceuticals in a research […]

ValuEngine lowered shares of PDL BioPharma (NASDAQ:PDLI) from a buy rating to a hold rating in a research report report published on Thursday morning, ValuEngine reports. A number of other research firms have also issued reports on PDLI. BidaskClub lowered PDL BioPharma from a hold rating to a sell rating in a report on Saturday, […]

Greenlight Capital Re (NASDAQ:GLRE) was upgraded by stock analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a note issued to investors on Saturday, BidAskClub reports. Separately, ValuEngine raised Greenlight Capital Re from a “buy” rating to a “strong-buy” rating in a report on Friday, August 2nd. Shares of GLRE opened […]

Network International (LON:NETW) had its target price hoisted by JPMorgan Chase & Co. from GBX 560 ($7.32) to GBX 595 ($7.77) in a research report report published on Thursday morning, ThisIsMoney.Co.Uk reports. They currently have a neutral rating on the stock. NETW has been the subject of a number of other research reports. Berenberg Bank […]

UBS Group reaffirmed their neutral rating on shares of John Wood Group (LON:WG) in a research note released on Friday, ThisIsMoney.Co.Uk reports. WG has been the subject of a number of other reports. Royal Bank of Canada decreased their price objective on shares of John Wood Group from GBX 725 ($9.47) to GBX 670 ($8.75) […]

ValuEngine cut shares of Iclick Interactive Asia Group (NASDAQ:ICLK) from a buy rating to a hold rating in a report released on Thursday morning, ValuEngine reports. Separately, Zacks Investment Research cut shares of Iclick Interactive Asia Group from a buy rating to a hold rating in a research report on Saturday, August 3rd. ICLK stock […]

ValuEngine upgraded shares of BIOLASE (NASDAQ:BIOL) from a hold rating to a buy rating in a report published on Thursday morning, ValuEngine reports. BIOL has been the topic of a number of other research reports. Benchmark started coverage on shares of BIOLASE in a research note on Wednesday, June 19th. They set a speculative buy […]

Zacks Investment Research upgraded shares of GLENCORE PLC/ADR (OTCMKTS:GLNCY) from a sell rating to a hold rating in a research note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Glencore Plc operates as a diversified natural resource company. It operates in three groups: Metals and Minerals, Energy Products, and Agricultural Products. The Metals […]